AMAG Pharmaceuticals Reports Lower-Than-Expected Q4 Loss

by Monica Gerson, Benzinga Staff Writer
February 25, 2011 7:12 AM | 17 seconds read |
AMAG Pharmaceuticals Inc AMAG reports its Q4 loss at $0.94 per share, versus the expected loss of $1.04 per share. AMAG reports its Q4 revenue at $17.2 million, versus the consensus of $16.76 million. AMAG shares gained 0.47% to close at $17.24 yesterday. Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: EarningsNewsEarningsHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!